Altering physical properties of pharmaceutical co-crystals in a systematic manner

Using Dissolution and Pharmacokinetics Studies of Crystal Form to Optimize the Original Iloperidone

(2013) Tingting Zhang et al.   CRYSTAL GROWTH & DESIGN

Diversity in Itraconazole Cocrystals with Aliphatic Dicarboxylic Acids of Varying Chain Length

(2013) Anna Shevchenko et al.   CRYSTAL GROWTH & DESIGN

Olanzapinium Salts, Isostructural Solvates, and Their Physicochemical Properties

(2013) Ranjit Thakuria et al.   CRYSTAL GROWTH & DESIGN

Lamivudine salts with 1,2-dicarboxylic acids: A new and a rare synthon with double pairing motif fine-tuning their solubility

(2013) Cameron Capeletti da Silva et al.   CRYSTENGCOMM

Novel pharmaceutical compositions through co-crystallization of racetams and Li+ salts

(2013) Johan Wouters et al.   CRYSTENGCOMM

Halogen Bonding and Pharmaceutical Cocrystals: The Case of a Widely Used Preservative

(2013) Michele Baldrighi et al.   MOLECULAR PHARMACEUTICS

Salt and Cocrystals of Sildenafil with Dicarboxylic Acids: Solubility and Pharmacokinetic Advantage of the Glutarate Salt

(2013) Palash Sanphui et al.   MOLECULAR PHARMACEUTICS

An experimental screen for quinoline/fumaric acid salts and co-crystals

(2012) Sándor L. Bekö et al.   CRYSTENGCOMM

Co-crystals of caffeine with substituted nitroanilines and nitrobenzoic acids: Structure–mechanical property and thermal studies

(2012) Soumyajit Ghosh et al.   CRYSTENGCOMM

The effect of water molecules in stabilizing co-crystals of active pharmaceutical ingredients

(2012) Christer B. Aakeröy et al.   CRYSTENGCOMM

Supramolecular constructs and thermodynamic stability of four polymorphs and a co-crystal of pentobarbital (nembutal)

(2012) Denise Rossi et al.   CRYSTENGCOMM

Interdependence of structure and physical properties in co-crystals of azopyridines

(2012) Christer B. Aakeröy et al.   CRYSTENGCOMM

Rapid preparation of pharmaceutical co-crystals with thermal ink-jet printing

(2012) Asma B. M. Buanz et al.   CRYSTENGCOMM

Specialized Solid Form Screening Techniques

(2012) Ann Newman   ORGANIC PROCESS RESEARCH & DEVELOPMENT

Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals

(2011) N. Jagadeesh Babu et al.   CRYSTAL GROWTH & DESIGN

Co-crystals of the antiretroviral nevirapine: crystal structures, thermal analysis and dissolution behaviour

(2011) Mino R. Caira et al.   CRYSTENGCOMM

Characterization, physicochemical and photo-stability of a co-crystal involving an antibioticdrug, nitrofurantoin, and 4-hydroxybenzoic acid

(2010) Venu R. Vangala et al.   CRYSTENGCOMM

Pharmaceutical Cocrystals and Their Physicochemical Properties

(2009) Nate Schultheiss et al.   CRYSTAL GROWTH & DESIGN

Using Cocrystals To Systematically Modulate Aqueous Solubility and Melting Behavior of an Anticancer Drug

(2009) Christer B. Aakeröy et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Applying Hot-Stage Microscopy to Co-Crystal Screening: A Study of Nicotinamide with Seven Active Pharmaceutical Ingredients

(2008) David J. Berry et al.   CRYSTAL GROWTH & DESIGN

Co-crystallisation of 2,2′-dithiodibenzoic acid with the isomeric n-pyridinealdazines, n = 2, 3 and 4: supramolecular polymers and the influence of steric factors upon aggregation patterns

(2008) Grant A. Broker et al.   CRYSTENGCOMM

Crystal engineering of nanoporous architectures and chiral porphyrin assemblies

(2008) Israel Goldberg   CRYSTENGCOMM

The role of cocrystals in pharmaceutical science

(2008) Ning Shan et al.   DRUG DISCOVERY TODAY